Listar por tema "Kanamycin/therapeutic use"

Mostrando ítems 1-1 de 1

Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay

Trollip, A. P.; Moore, David Alexander James; Coronel, J.; Caviedes, L.; Klages, S.; Victor, T.; Romancenco, E.; Crudu, V.; Ajbani, K.; Vineet, V. P.; Rodrigues, C.; Jackson, R. L.; Eisenach, K.; Garfein, R. S.; Rodwell, T. C.; Desmond, E.; Groessl, E. J.; Ganiats, T. G.; Catanzaro, A. (International Union Against Tuberculosis and Lung Disease, 2014)

OBJECTIVE: To establish breakpoint concentrations for the fluoroquinolones (moxifloxacin [MFX] and ofloxacin [OFX]) and injectable second-line drugs (amikacin [AMK], kanamycin [KM] and capreomycin [CPM]) using the microscopic ...